In 2009, Abby Alonzo was told that she had Hodgkin’s lymphoma, a cancer of the immune system. With the proper regimen studies show that there is a 90% chance that the disease can be beat. In 2010 however, Abby and her mother Katie was told that there was a shortage on one of the drugs that she needed, which was mechlorethamine. Due to the shortage Abby had to use the generic brand. Studies have shown that 88% of the people taking the original are still alive, but the generic brand, 75%. The question is, how can there be a shortage? Drop down bottom for the answer as well as how Abby’s doing now.

JaaiR (JR)

CBS News